Latest Breaking News On - Venturebeat terms of service - Page 1 : vimarsana.com

GitHub Accelerator fuels open source AI revolution, empowering startups to democratize access

GitHub's AI Accelerator ignites open source revolution, empowering startups like Unsloth and Formbricks to democratize access to cutting-edge AI technologies and challenge big tech's dominance in the field.

SAP adds Amazon Bedrock to its AI Core to boost enterprise gen AI adoption

SAP is deepening its AWS partnership, integrating Amazon Bedrock into its AI Core to streamling access for those in regulated firms.

Microsoft, Beihang release MoRA, an efficient LLM fine-tuning technique

MoRA is a new LLM fine-tuning technique that solves some of the problems of other parameter-efficient techniques such as LoRA.

OpenAI begins training new frontier model

OpenAI's board of directors, many of which are now on the new Safety and Security Committee, has been a source of controversy before.

Why cellular-first SASE is defining the future of distributed enterprises

Elon Musk and Yann LeCun's social media feud highlights key differences in approach to AI research and hype

Elon Musk and Meta's AI Chief Yann LeCun clash on Twitter over the future of AI research, development, and self-driving technology.

Elon Musk's xAI raises $6B to take on OpenAI

xAI is expected to pump the money to enhance the capabilities of Grok and build an AI supercomputer to train and run its next version.

Cohere launches open weights, multilingual AI model Aya 23

To provide access to this research, the company has released the open weights for both the 8B and 35B Aya 23 models on Hugging Face.

Nvidia says 20K AI startups are building on its platform

Huang emphasized that Ethernet is a major new opportunity for Nvidia to bring AI computing to a wider market.

McKesson, Merck back Atropos Health's $33M round to accelerate drug development with AI

Atropos Health raises $33 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development.